Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BCRX | Common Stock | Award | $0 | +16.7K | +21.48% | $0.00 | 94.7K | Jun 13, 2023 | Direct | F1 |
transaction | BCRX | Common Stock | Sale | -$103K | -12.9K | -13.59% | $8.04 | 81.8K | Jun 14, 2023 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BCRX | Automatic Stock Option Grant | Award | $0 | +39.1K | $0.00 | 39.1K | Jun 13, 2023 | Common Stock | 39.1K | $8.18 | Direct | F3 |
Id | Content |
---|---|
F1 | Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant. |
F2 | The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $7.89 to $8.12. The reporting person will provide to the issuer, or any security holder of the issuer, or the SEC staff upon request, full information regarding the number of shares purchased at each price within the range set forth in the footnote. |
F3 | Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy. |